Pharmocann Global Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Meir Shimon
Chief executive officer
₪849.1k
Total compensation
| CEO salary percentage | 72.4% |
| CEO tenure | 1.7yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 1.7yrs |
Recent management updates
Recent updates
The Returns On Capital At Pharmocann Global (TLV:PMCN) Don't Inspire Confidence
Mar 30
Should You Use Pharmocann Global's (TLV:PMCN) Statutory Earnings To Analyse It?
Feb 04Pharmocann Global Ltd (TLV:PMCN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Dec 31
The Returns At Pharmocann Global (TLV:PMCN) Provide Us With Signs Of What's To Come
Nov 26CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -₪10m |
| Mar 31 2024 | n/a | n/a | -₪10m |
| Dec 31 2023 | ₪849k | ₪615k | -₪10m |
Compensation vs Market: Meir's total compensation ($USD229.08K) is below average for companies of similar size in the IL market ($USD420.85K).
Compensation vs Earnings: Insufficient data to compare Meir's compensation with company performance.
CEO
Meir Shimon
1.7yrs
Tenure
₪849,055
Compensation
Mr. Meir Shimon is CEO & Director of Pharmocann Global Ltd from March 15, 2023.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 1.7yrs | ₪849.06k | no data | |
| Chairman of the Board | no data | ₪589.00k | no data | |
| Director | 5.4yrs | ₪211.00k | no data | |
| External Independent Director | no data | no data | no data | |
| Independent Director | no data | no data | no data | |
| External Independent Director | less than a year | no data | no data |
1.7yrs
Average Tenure
43yo
Average Age
Experienced Board: PMCN-M's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.